Basic Information
Duloxetine Lilly
Regulatory Information
EMEA/H/C/004000
December 8, 2014
October 23, 2014
10
July 9, 2024
Company Information
Netherlands
Papendorpseweg 83 3528 BJ Utrecht
Eli Lilly Nederland BV
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Duloxetine Lilly is indicated in adults for: - Treatment of major depressive disorder - Treatment of diabetic peripheral neuropathic pain - Treatment of generalised anxiety disorder Duloxetine Lilly is indicated in adults.
Overview Summary
This is a summary of the European public assessment report (EPAR) for Duloxetine Lilly. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Duloxetine Lilly. For practical information about using Duloxetine Lilly, patients should read the package leaflet or contact their doctor or pharmacist.